Lexicon regains Nasdaq minimum bid price compliance; deficiency closed

LEXICON PHARMACEUTICALS, INC.

Received letter from Nasdaq on July 23, 2025 confirming compliance with $1 minimum bid price rule.
Matter related to previous failure to meet bid price requirement is now closed.
Common stock (LXRX) continues trading on Nasdaq Global Select Market.

item 8.01

LEXICON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001062822-25-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.